Gene therapy strategies for the treatment of chronic viral hepatitis.
about
Anti-HBV activity of TRL mediated by recombinant adenovirusVP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication.Inhibition of HBV targeted ribonuclease enhanced by introduction of linkerInhibition effect produced by dominant negative mutant fusion protein PreS2-TLM-ScFv-HBcDN on HBV replication in vitro.
P2860
Gene therapy strategies for the treatment of chronic viral hepatitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gene therapy strategies for the treatment of chronic viral hepatitis.
@ast
Gene therapy strategies for the treatment of chronic viral hepatitis.
@en
Gene therapy strategies for the treatment of chronic viral hepatitis.
@nl
type
label
Gene therapy strategies for the treatment of chronic viral hepatitis.
@ast
Gene therapy strategies for the treatment of chronic viral hepatitis.
@en
Gene therapy strategies for the treatment of chronic viral hepatitis.
@nl
prefLabel
Gene therapy strategies for the treatment of chronic viral hepatitis.
@ast
Gene therapy strategies for the treatment of chronic viral hepatitis.
@en
Gene therapy strategies for the treatment of chronic viral hepatitis.
@nl
P2093
P2860
P356
P1476
Gene therapy strategies for the treatment of chronic viral hepatitis.
@en
P2093
P2860
P304
P356
10.1517/14712598.1.4.629
P407
P577
2001-07-01T00:00:00Z